Sort
130,381 grants matching “hiv”
Novel Diagnostic Sequencing System for HIV Resistance Testing
$994,055Jerzy Olejnik · Intelligent Bio-Systems, Inc. · R44 · FY2011 · AI
Technology Development for 3D Electron Microscopy
$994,049Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
In vivo testing of novel HIV Env vaccine platforms to advance preclinical HIV vaccine development
$993,962Gavin Morrow · International Aids Vaccine Initiative · P01 · FY2020 · AI
Core B
$993,882Galit Alter · Beth Israel Deaconess Medical Center · U19 · FY2022 · AI
mRNA-based chimeric membrane protein vaccination strategies directed at the MPER
$993,881Mikyung Kim · Dana-Farber Cancer Inst · P01 · FY2025 · AI
HIV Persistence During Suppressive Antiretroviral Therapy
$993,764Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$993,747Roger L Shapiro · Harvard School Of Public Health · U01 · FY2023 · AI
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$993,703Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Conformational Stabilization of the HIV-1 Env Trimer
$993,663Christopher Marshall · Avatar Medical, Llc · R44 · FY2014 · AI
Viral Replication and Interactions with Host Factors
$993,604Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Structure and Function of Vif and APOBEC3 (A3) Proteins
$993,604Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Midwest Developmental Center for AIDS Research (D-CFAR)
$993,578Elvin H. Geng · Washington University · P30 · FY2025 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$993,528Univ Of Massachusetts Med Sch Worcester · U01 · FY2003 · AI
Technology-based Treatments for Substance Use Disorders
$993,464Lisa A Marsch · Dartmouth College · P30 · FY2015 · DA
HIV Risk Reduction for Black Drug-Using Women
$993,390University Of Pennsylvania · R01 · FY2003 · MH
HIV PREVENTION AND CARE SERVICES FOR MARPS IN CENTRAL PROVINCE
$993,373Elizabeth Njeri Ngugi · University Of Nairobi · U2G · FY2013 · PS
The mucosal immune system: effects of aging and chronic antigenic stimulation
$993,364Rita Brickman Effros · University Of California Los Angeles · R01 · FY2012 · AG
Reducing Risk & Enhancing Protective Factors in Children
$993,233Richard F Catalano · University Of Washington · R01 · FY2008 · DA
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine
$993,161Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2018 · AI
Trimer Production and Immunogenicity Testing
$993,090John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2014 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$993,079Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
BODY COMPOSITION: METHODS, MODEL &CLINICAL APPLICATION
$993,053St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2005 · DK
SDMC: HIV Vaccine Trials Network
$992,886Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.
$992,797Iain James Macleod · Aldatu Biosciences, Inc. · SB1 · FY2022 · AI
Molecular Detection of Invasive Fungal Infections
$992,788Andrew E. Levin · Immunetics, Inc. · R44 · FY2015 · AI